Treatments & Surgery
Share your love
New research uncovers promising treatment for neurodegenerative diseases like ALS, glaucoma | Ophthalmology – Stanford Medicine
New research uncovers promising treatment for neurodegenerative diseases like ALS, glaucoma | Ophthalmology Stanford Medicine Source: Author: | Date: 2025-02-20 08:00:00 Source: Author: | Date: 2025-02-20 08:00:00
NEI Study Reveals Annexin-V’s Role in Retinal Diseases
A recent study led by the National Eye Institute (NEI) has revealed new insights into annexin-V, a key biomarker traditionally used to track apoptosis (programmed cell death) and retinal cell degeneration in eye diseases. Published in the International Journal of…
2023 Recap: Top 15 Research in Ophthalmology
2024 Recap is here! Click to review:Top 10 Breakthroughs in Ophthalmology Research In the fast-evolving landscape of ophthalmology research, 2023 has proven to be a pivotal year marked by groundbreaking discoveries and innovation. From revolutionary cell replacement therapies to novel…
ACELYRIN Halts Izokibep Development | OBN
ACELYRIN has announced that the Phase 2b/3 clinical trial evaluating izokibep for non-infectious, non-anterior uveitis did not achieve its primary endpoint. The trial results did not demonstrate a statistically significant improvement in time to treatment failure versus placebo. Consequently, the…
Tenpoint and Visus Merge to Advance Eye Care
Tenpoint Therapeutics Ltd. and Visus Therapeutics Inc. have officially merged, combining their respective ophthalmic therapeutic assets to form a unified entity focused on addressing ocular conditions associated with aging, including presbyopia, cataracts, and geographic atrophy. Key Therapeutics in the Combined…
ViaLase, Moran Eye Center Collaborate on Glaucoma
ViaLase has announced a groundbreaking research partnership with the John A. Moran Eye Center at the University of Utah, home to the Alan S. Crandall Center for Glaucoma Innovation. This collaboration aims to accelerate glaucoma research by utilizing Moran’s state-of-the-art…
First Inverted Meniscus Optics IOLs by Voptica
*This exclusive article is sponsored by Voptica. The opinions expressed in this article are the sponsor’s own. Intraocular lenses (IOLs) designs are constantly evolving to improve patients’ vision needs. Trifocal diffractive IOLs are designed to achieve good visual acuity at…
Yamane Technique – Intrascleral IOL Fixation
In cataract surgery, the optimal outcome involves implanting an intraocular lens (IOL) within the capsular bag. However, complications such as posterior capsule rupture, congenital lens anomalies, or traumatic injuries can leave patients without adequate capsular support, resulting in aphakia—a condition…
Researchers Find 101 Genetic Links to Cataracts
In the largest genetic study on cataracts to date, researchers from QIMR Berghofer Medical Research Institute have identified 101 genetic regions associated with an increased risk of developing cataracts. This groundbreaking study analyzed DNA from over 950,000 individuals, providing significant…
Blood Pressure Variability Tied to Glaucoma Vision Loss
A study led by researchers at the University of California, San Diego, reveals that long-term variability in blood pressure is associated with an accelerated decline in peripheral vision caused by glaucoma progression. The findings highlight the role of vascular factors…